A major breakthrough in cancer study is occurring with the use of nanobodies to reactivate dysfunctional p53. This essential malignant suppressor protein is frequently disabled in various kinds of cancer, causing https://iowa-bookmarks.com/story17835192/mini-antibodies-revive-p53-the-new-approach-for-cancer-treatment